Metagenomi (MGX) Income from Continuing Operations (2023 - 2025)
Historic Income from Continuing Operations for Metagenomi (MGX) over the last 3 years, with Q3 2025 value amounting to -$20.4 million.
- Metagenomi's Income from Continuing Operations fell 862.94% to -$20.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$88.7 million, marking a year-over-year decrease of 1999.08%. This contributed to the annual value of -$78.1 million for FY2024, which is 1436.23% down from last year.
- Metagenomi's Income from Continuing Operations amounted to -$20.4 million in Q3 2025, which was down 862.94% from -$19.9 million recorded in Q2 2025.
- In the past 5 years, Metagenomi's Income from Continuing Operations ranged from a high of -$10.7 million in Q2 2024 and a low of -$25.1 million during Q1 2024
- Its 3-year average for Income from Continuing Operations is -$18.8 million, with a median of -$19.8 million in 2023.
- Examining YoY changes over the last 5 years, Metagenomi's Income from Continuing Operations showed a top increase of 1744.31% in 2024 and a maximum decrease of 11422.61% in 2024.
- Over the past 3 years, Metagenomi's Income from Continuing Operations (Quarter) stood at -$19.3 million in 2023, then dropped by 21.27% to -$23.4 million in 2024, then grew by 12.84% to -$20.4 million in 2025.
- Its Income from Continuing Operations stands at -$20.4 million for Q3 2025, versus -$19.9 million for Q2 2025 and -$25.0 million for Q1 2025.